Heart Failure
Conditions
Keywords
CareLink, Remote Monitoring, Cardiac Pacemaker, Artificial, Implantable Cardioverter-Defibrillators
Brief summary
The purpose of the study is to demonstrate the value of the Medtronic CareLink® Network in clinical practice in the country specific healthcare setting.
Detailed description
Evaluation's objectives: Comparison of remote device check and in-clinic device assessment. To assess patient ease of use of, and satisfaction with, the Medtronic CareLink® Monitor To assess clinician ease of use of, and satisfaction with, the Medtronic CareLink® Monitor and Website To assess the clinic specific clinical value of Medtronic CareLink® Network Demonstrate time savings for patients Demonstrate time savings for physicians To show the increase of efficiency through increased flexibility and per procedure time To demonstrate better handling of unscheduled activities (symptoms, events, etc.)
Interventions
The Medtronic CareLink® Network consists of the Medtronic CareLink® Monitor and Medtronic CareLink® Clinician Website
Sponsors
Study design
Eligibility
Inclusion criteria
* Patients who have an implanted Medtronic ICD, CRT-D device that is supported by the Medtronic CareLink® Network * Patients have to sign the Medtronic CareLink® Statement of Privacy Principles and the Evaluation Data Protection Statement documents
Exclusion criteria
* Patients with
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Comparison of Remote Device Check and In-clinic Device Assessment | Baseline to max. 12 months | Investigators were asked the following question: how did the Medtronic CareLink system matched their personal expectation/goals and had to answer with multiple answer using the following ranking Significantly exceeded, Goals met, No expectations, Not met, Not met at all: Question 1) Newest technology for my patients. Q2) Increased patient safety. Q3) Increased patient satisfaction. Q4) Improved quality of life for my patients. Q5) Improved follow up after therapy/shock delivery of for symptomatic patients, adverse events. Q6) Increased hospital efficiency. Q7) Increased follow up quality. Q8) More flexible follow up schemes possible. Q9) Better management of the increased number of follow ups. Q10) Increased satisfaction of hospital personnel. Q11) Other goals |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Clinician Ease of Use of, and Satisfaction With, the Medtronic CareLink® Monitor and Website (Including Clinician General Preference, if Any, for Medtronic CareLink® Compared to Traditional In-clinic Device Follow-up) | Baseline to max. 12 months | — |
| Clinic-specific Clinical Value of Medtronic CareLink® Network (Change of Workflow, Increase of Flexibility) | Baseline to max. 12 months | — |
| Time and Cost Savings for Patients | Baseline to max. 12 months | — |
| Patient Ease of Use of, and Satisfaction With the Medtronic CareLink® Monitor (Including Percentage of Patients Who Prefer Follow up With Medtronic CareLink® Compared to Traditional In-clinic Device Follow-up) | Baseline to max. 12 months | Participants were asked questions to which they could have respond multiple answers. 1) Which form of device follow up do you prefer? Answers: Monitor from home and in hospital follow up is necessary; Follow up only in hospital; No preference, and 2) How would you judge the user friendliness of the monitor in total? Answers: Very easy; Easy; Difficult; Missing Data, and 3) How did the monitor changed your daily life? did you felt more or less safe? Answers: Much more safe; Safe; No influence; Unsafe; Missing data |
| Efficiency Through Increased Flexibility and Per Procedure Time | Baseline to max. 12 months | — |
| Handling of Unscheduled Activities (for Example, Symptoms and Events) | Baseline to max. 12 months | Investigators were asked to classify reasons for unscheduled visits by marking all applicable answers. Answer: 1) patient symptoms 2) adequate therapy/shock 3) appearance of already known arrythmias 4) appearance of new arrythmias 5) need for reprogramming 6) in house Follow-up 7) device alert 8) inadequate therapy/shock 9) worsening of pump function 10) malfunction of the device 11) other |
| Time and Costs Savings for Physicians | Baseline to max. 12 months | — |
Countries
Poland
Participant flow
Participants by arm
| Arm | Count |
|---|---|
| Medtronic CareLink® Network Patients with implanted ICD or CRT-D devices, who will be monitored by the Medtronic CareLink® System.
The System consists of the Medtronic CareLink® Monitor and Medtronic CareLink® Clinician Website.
Medtronic CareLink® Network: The Medtronic CareLink® Network consists of the Medtronic CareLink® Monitor and Medtronic CareLink® Clinician Website | 176 |
| Total | 176 |
Withdrawals & dropouts
| Period | Reason | FG000 |
|---|---|---|
| Overall Study | Death | 5 |
| Overall Study | due to technical issues | 2 |
| Overall Study | Lost to Follow-up | 7 |
Baseline characteristics
| Characteristic | Medtronic CareLink® Network |
|---|---|
| Age, Categorical <=18 years | 0 Participants |
| Age, Categorical >=65 years | 73 Participants |
| Age, Categorical Between 18 and 65 years | 103 Participants |
| Age, Continuous | 61 years STANDARD_DEVIATION 13 |
| Region of Enrollment Poland | 176 participants |
| Sex: Female, Male Female | 29 Participants |
| Sex: Female, Male Male | 147 Participants |
Adverse events
| Event type | EG000 affected / at risk |
|---|---|
| deaths Total, all-cause mortality | — / — |
| other Total, other adverse events | 0 / 0 |
| serious Total, serious adverse events | 5 / 176 |
Outcome results
Comparison of Remote Device Check and In-clinic Device Assessment
Investigators were asked the following question: how did the Medtronic CareLink system matched their personal expectation/goals and had to answer with multiple answer using the following ranking Significantly exceeded, Goals met, No expectations, Not met, Not met at all: Question 1) Newest technology for my patients. Q2) Increased patient safety. Q3) Increased patient satisfaction. Q4) Improved quality of life for my patients. Q5) Improved follow up after therapy/shock delivery of for symptomatic patients, adverse events. Q6) Increased hospital efficiency. Q7) Increased follow up quality. Q8) More flexible follow up schemes possible. Q9) Better management of the increased number of follow ups. Q10) Increased satisfaction of hospital personnel. Q11) Other goals
Time frame: Baseline to max. 12 months
Population: Number of Investigators who provided responded for these questions at the end of evaluation.
| Arm | Measure | Group | Value (NUMBER) |
|---|---|---|---|
| Medtronic CareLink® Network | Comparison of Remote Device Check and In-clinic Device Assessment | Answer for Question 1: Goals met | 50.0 percentage of Investigators |
| Medtronic CareLink® Network | Comparison of Remote Device Check and In-clinic Device Assessment | Answer for Question 4:Not met at all | 0.0 percentage of Investigators |
| Medtronic CareLink® Network | Comparison of Remote Device Check and In-clinic Device Assessment | Answer for Qestion 5: Significantly exceeded | 30.0 percentage of Investigators |
| Medtronic CareLink® Network | Comparison of Remote Device Check and In-clinic Device Assessment | Answer for Question 5: No expectations | 0.0 percentage of Investigators |
| Medtronic CareLink® Network | Comparison of Remote Device Check and In-clinic Device Assessment | Answer for Question 10:Not met | 20.0 percentage of Investigators |
| Medtronic CareLink® Network | Comparison of Remote Device Check and In-clinic Device Assessment | Answer for Qestion 1: Significantly exceeded | 40.0 percentage of Investigators |
| Medtronic CareLink® Network | Comparison of Remote Device Check and In-clinic Device Assessment | Answer for Question 1: No expectations | 10.0 percentage of Investigators |
| Medtronic CareLink® Network | Comparison of Remote Device Check and In-clinic Device Assessment | Answer for Question 1:Not met | 0.0 percentage of Investigators |
| Medtronic CareLink® Network | Comparison of Remote Device Check and In-clinic Device Assessment | Answer for Question 1:Not met at all | 0.0 percentage of Investigators |
| Medtronic CareLink® Network | Comparison of Remote Device Check and In-clinic Device Assessment | Answer for Qestion 2: Significantly exceeded | 20 percentage of Investigators |
| Medtronic CareLink® Network | Comparison of Remote Device Check and In-clinic Device Assessment | Answer for Question 2: Goals met | 80 percentage of Investigators |
| Medtronic CareLink® Network | Comparison of Remote Device Check and In-clinic Device Assessment | Answer for Question 2: No expectations | 0.0 percentage of Investigators |
| Medtronic CareLink® Network | Comparison of Remote Device Check and In-clinic Device Assessment | Answer for Question 2:Not met | 0.0 percentage of Investigators |
| Medtronic CareLink® Network | Comparison of Remote Device Check and In-clinic Device Assessment | Answer for Question 2:Not met at all | 0.0 percentage of Investigators |
| Medtronic CareLink® Network | Comparison of Remote Device Check and In-clinic Device Assessment | Answer for Qestion 3: Significantly exceeded | 10.0 percentage of Investigators |
| Medtronic CareLink® Network | Comparison of Remote Device Check and In-clinic Device Assessment | Answer for Question 3: Goals met | 70.0 percentage of Investigators |
| Medtronic CareLink® Network | Comparison of Remote Device Check and In-clinic Device Assessment | Answer for Question 3: No expectations | 20.0 percentage of Investigators |
| Medtronic CareLink® Network | Comparison of Remote Device Check and In-clinic Device Assessment | Answer for Question 3:Not met | 0.0 percentage of Investigators |
| Medtronic CareLink® Network | Comparison of Remote Device Check and In-clinic Device Assessment | Answer for Question 3:Not met at all | 0.0 percentage of Investigators |
| Medtronic CareLink® Network | Comparison of Remote Device Check and In-clinic Device Assessment | Answer for Qestion 4: Significantly exceeded | 10.0 percentage of Investigators |
| Medtronic CareLink® Network | Comparison of Remote Device Check and In-clinic Device Assessment | Answer for Question 4: Goals met | 70.0 percentage of Investigators |
| Medtronic CareLink® Network | Comparison of Remote Device Check and In-clinic Device Assessment | Answer for Question 4: No expectations | 20.0 percentage of Investigators |
| Medtronic CareLink® Network | Comparison of Remote Device Check and In-clinic Device Assessment | Answer for Question 4:Not met | 0.0 percentage of Investigators |
| Medtronic CareLink® Network | Comparison of Remote Device Check and In-clinic Device Assessment | Answer for Question 5: Goals met | 70.0 percentage of Investigators |
| Medtronic CareLink® Network | Comparison of Remote Device Check and In-clinic Device Assessment | Answer for Question 5:Not met | 0.0 percentage of Investigators |
| Medtronic CareLink® Network | Comparison of Remote Device Check and In-clinic Device Assessment | Answer for Question 5:Not met at all | 0.0 percentage of Investigators |
| Medtronic CareLink® Network | Comparison of Remote Device Check and In-clinic Device Assessment | Answer for Qestion 6: Significantly exceeded | 10.0 percentage of Investigators |
| Medtronic CareLink® Network | Comparison of Remote Device Check and In-clinic Device Assessment | Answer for Question 6: Goals met | 20.0 percentage of Investigators |
| Medtronic CareLink® Network | Comparison of Remote Device Check and In-clinic Device Assessment | Answer for Question 6: No expectations | 70.0 percentage of Investigators |
| Medtronic CareLink® Network | Comparison of Remote Device Check and In-clinic Device Assessment | Answer for Question 6:Not met | 0.0 percentage of Investigators |
| Medtronic CareLink® Network | Comparison of Remote Device Check and In-clinic Device Assessment | Answer for Question 6:Not met at all | 0.0 percentage of Investigators |
| Medtronic CareLink® Network | Comparison of Remote Device Check and In-clinic Device Assessment | Answer for Qestion 7: Significantly exceeded | 10.0 percentage of Investigators |
| Medtronic CareLink® Network | Comparison of Remote Device Check and In-clinic Device Assessment | Answer for Question 7: Goals met | 60.0 percentage of Investigators |
| Medtronic CareLink® Network | Comparison of Remote Device Check and In-clinic Device Assessment | Answer for Question 7: No expectations | 30.0 percentage of Investigators |
| Medtronic CareLink® Network | Comparison of Remote Device Check and In-clinic Device Assessment | Answer for Question 7:Not met | 0.0 percentage of Investigators |
| Medtronic CareLink® Network | Comparison of Remote Device Check and In-clinic Device Assessment | Answer for Question 7:Not met at all | 0.0 percentage of Investigators |
| Medtronic CareLink® Network | Comparison of Remote Device Check and In-clinic Device Assessment | Answer for Qestion 8: Significantly exceeded | 20.0 percentage of Investigators |
| Medtronic CareLink® Network | Comparison of Remote Device Check and In-clinic Device Assessment | Answer for Question 8: Goals met | 60.0 percentage of Investigators |
| Medtronic CareLink® Network | Comparison of Remote Device Check and In-clinic Device Assessment | Answer for Question 8: No expectations | 20.0 percentage of Investigators |
| Medtronic CareLink® Network | Comparison of Remote Device Check and In-clinic Device Assessment | Answer for Question 8:Not met | 0.0 percentage of Investigators |
| Medtronic CareLink® Network | Comparison of Remote Device Check and In-clinic Device Assessment | Answer for Question 8:Not met at all | 0.0 percentage of Investigators |
| Medtronic CareLink® Network | Comparison of Remote Device Check and In-clinic Device Assessment | Answer for Qestion 9: Significantly exceeded | 20.0 percentage of Investigators |
| Medtronic CareLink® Network | Comparison of Remote Device Check and In-clinic Device Assessment | Answer for Question 9: Goals met | 60.0 percentage of Investigators |
| Medtronic CareLink® Network | Comparison of Remote Device Check and In-clinic Device Assessment | Answer for Question 9: No expectations | 20 percentage of Investigators |
| Medtronic CareLink® Network | Comparison of Remote Device Check and In-clinic Device Assessment | Answer for Question 9:Not met | 0.0 percentage of Investigators |
| Medtronic CareLink® Network | Comparison of Remote Device Check and In-clinic Device Assessment | Answer for Question 9:Not met at all | 0.0 percentage of Investigators |
| Medtronic CareLink® Network | Comparison of Remote Device Check and In-clinic Device Assessment | Answer for Qestion 10: Significantly exceeded | 10.0 percentage of Investigators |
| Medtronic CareLink® Network | Comparison of Remote Device Check and In-clinic Device Assessment | Answer for Question 10: Goals met | 20.0 percentage of Investigators |
| Medtronic CareLink® Network | Comparison of Remote Device Check and In-clinic Device Assessment | Answer for Question 10: No expectations | 50.0 percentage of Investigators |
| Medtronic CareLink® Network | Comparison of Remote Device Check and In-clinic Device Assessment | Answer for Question 10:Not met at all | 0.0 percentage of Investigators |
| Medtronic CareLink® Network | Comparison of Remote Device Check and In-clinic Device Assessment | Answer for Qestion 11: Significantly exceeded | 0.0 percentage of Investigators |
| Medtronic CareLink® Network | Comparison of Remote Device Check and In-clinic Device Assessment | Answer for Question 11: Goals met | 0.0 percentage of Investigators |
| Medtronic CareLink® Network | Comparison of Remote Device Check and In-clinic Device Assessment | Answer for Question 11: No expectations | 0.0 percentage of Investigators |
| Medtronic CareLink® Network | Comparison of Remote Device Check and In-clinic Device Assessment | Answer for Question 11:Not met | 0.0 percentage of Investigators |
| Medtronic CareLink® Network | Comparison of Remote Device Check and In-clinic Device Assessment | Answer for Question 11:Not met at all | 0.0 percentage of Investigators |
Clinician Ease of Use of, and Satisfaction With, the Medtronic CareLink® Monitor and Website (Including Clinician General Preference, if Any, for Medtronic CareLink® Compared to Traditional In-clinic Device Follow-up)
Time frame: Baseline to max. 12 months
Clinic-specific Clinical Value of Medtronic CareLink® Network (Change of Workflow, Increase of Flexibility)
Time frame: Baseline to max. 12 months
Efficiency Through Increased Flexibility and Per Procedure Time
Time frame: Baseline to max. 12 months
Handling of Unscheduled Activities (for Example, Symptoms and Events)
Investigators were asked to classify reasons for unscheduled visits by marking all applicable answers. Answer: 1) patient symptoms 2) adequate therapy/shock 3) appearance of already known arrythmias 4) appearance of new arrythmias 5) need for reprogramming 6) in house Follow-up 7) device alert 8) inadequate therapy/shock 9) worsening of pump function 10) malfunction of the device 11) other
Time frame: Baseline to max. 12 months
Population: The 68 patients of total population (176) were analyzed as this number of pt. had experienced unscheduled visit during the study.
| Arm | Measure | Group | Value (NUMBER) |
|---|---|---|---|
| Medtronic CareLink® Network | Handling of Unscheduled Activities (for Example, Symptoms and Events) | Reason 1: patient symptoms | 25.9 % of unscheduled visits due to reasons |
| Medtronic CareLink® Network | Handling of Unscheduled Activities (for Example, Symptoms and Events) | Reason 2: adequate therapy/shock | 14.7 % of unscheduled visits due to reasons |
| Medtronic CareLink® Network | Handling of Unscheduled Activities (for Example, Symptoms and Events) | Reason 3: appearance of already known arrythmias | 0.9 % of unscheduled visits due to reasons |
| Medtronic CareLink® Network | Handling of Unscheduled Activities (for Example, Symptoms and Events) | Reason 4:appearance of new arrythmias | 2.6 % of unscheduled visits due to reasons |
| Medtronic CareLink® Network | Handling of Unscheduled Activities (for Example, Symptoms and Events) | Reason 5: need of reprograming | 1.7 % of unscheduled visits due to reasons |
| Medtronic CareLink® Network | Handling of Unscheduled Activities (for Example, Symptoms and Events) | Reason 6: in house Fup after Carelink control | 4.3 % of unscheduled visits due to reasons |
| Medtronic CareLink® Network | Handling of Unscheduled Activities (for Example, Symptoms and Events) | Reason 7: device alert | 17.2 % of unscheduled visits due to reasons |
| Medtronic CareLink® Network | Handling of Unscheduled Activities (for Example, Symptoms and Events) | Reason 8: inadequate therapy/shock | 6.0 % of unscheduled visits due to reasons |
| Medtronic CareLink® Network | Handling of Unscheduled Activities (for Example, Symptoms and Events) | Reason 9: worsening of pump function | 0.9 % of unscheduled visits due to reasons |
| Medtronic CareLink® Network | Handling of Unscheduled Activities (for Example, Symptoms and Events) | Reason 10: malfunction of the device | 0.0 % of unscheduled visits due to reasons |
| Medtronic CareLink® Network | Handling of Unscheduled Activities (for Example, Symptoms and Events) | Reason 11: Other | 44.8 % of unscheduled visits due to reasons |
Patient Ease of Use of, and Satisfaction With the Medtronic CareLink® Monitor (Including Percentage of Patients Who Prefer Follow up With Medtronic CareLink® Compared to Traditional In-clinic Device Follow-up)
Participants were asked questions to which they could have respond multiple answers. 1) Which form of device follow up do you prefer? Answers: Monitor from home and in hospital follow up is necessary; Follow up only in hospital; No preference, and 2) How would you judge the user friendliness of the monitor in total? Answers: Very easy; Easy; Difficult; Missing Data, and 3) How did the monitor changed your daily life? did you felt more or less safe? Answers: Much more safe; Safe; No influence; Unsafe; Missing data
Time frame: Baseline to max. 12 months
Population: Number of patients who provided responses for these questions at the end of the Study.
| Arm | Measure | Group | Value (NUMBER) |
|---|---|---|---|
| Medtronic CareLink® Network | Patient Ease of Use of, and Satisfaction With the Medtronic CareLink® Monitor (Including Percentage of Patients Who Prefer Follow up With Medtronic CareLink® Compared to Traditional In-clinic Device Follow-up) | Question 1: Missing data | 0.7 percentage of patients |
| Medtronic CareLink® Network | Patient Ease of Use of, and Satisfaction With the Medtronic CareLink® Monitor (Including Percentage of Patients Who Prefer Follow up With Medtronic CareLink® Compared to Traditional In-clinic Device Follow-up) | Question 1: Monitor f. home & in hospital f-up is | 71.8 percentage of patients |
| Medtronic CareLink® Network | Patient Ease of Use of, and Satisfaction With the Medtronic CareLink® Monitor (Including Percentage of Patients Who Prefer Follow up With Medtronic CareLink® Compared to Traditional In-clinic Device Follow-up) | Question 1: Follow up only in hospital | 8.7 percentage of patients |
| Medtronic CareLink® Network | Patient Ease of Use of, and Satisfaction With the Medtronic CareLink® Monitor (Including Percentage of Patients Who Prefer Follow up With Medtronic CareLink® Compared to Traditional In-clinic Device Follow-up) | Question 1: No preference | 18.8 percentage of patients |
| Medtronic CareLink® Network | Patient Ease of Use of, and Satisfaction With the Medtronic CareLink® Monitor (Including Percentage of Patients Who Prefer Follow up With Medtronic CareLink® Compared to Traditional In-clinic Device Follow-up) | Question 2: Very easy | 65.1 percentage of patients |
| Medtronic CareLink® Network | Patient Ease of Use of, and Satisfaction With the Medtronic CareLink® Monitor (Including Percentage of Patients Who Prefer Follow up With Medtronic CareLink® Compared to Traditional In-clinic Device Follow-up) | Question 2: Easy | 32.9 percentage of patients |
| Medtronic CareLink® Network | Patient Ease of Use of, and Satisfaction With the Medtronic CareLink® Monitor (Including Percentage of Patients Who Prefer Follow up With Medtronic CareLink® Compared to Traditional In-clinic Device Follow-up) | Question 2: Difficult | 1.3 percentage of patients |
| Medtronic CareLink® Network | Patient Ease of Use of, and Satisfaction With the Medtronic CareLink® Monitor (Including Percentage of Patients Who Prefer Follow up With Medtronic CareLink® Compared to Traditional In-clinic Device Follow-up) | Question 2: Missing data | 0.7 percentage of patients |
| Medtronic CareLink® Network | Patient Ease of Use of, and Satisfaction With the Medtronic CareLink® Monitor (Including Percentage of Patients Who Prefer Follow up With Medtronic CareLink® Compared to Traditional In-clinic Device Follow-up) | Question 3: Much more safer | 44.3 percentage of patients |
| Medtronic CareLink® Network | Patient Ease of Use of, and Satisfaction With the Medtronic CareLink® Monitor (Including Percentage of Patients Who Prefer Follow up With Medtronic CareLink® Compared to Traditional In-clinic Device Follow-up) | Question 3: Safe | 50.3 percentage of patients |
| Medtronic CareLink® Network | Patient Ease of Use of, and Satisfaction With the Medtronic CareLink® Monitor (Including Percentage of Patients Who Prefer Follow up With Medtronic CareLink® Compared to Traditional In-clinic Device Follow-up) | Question 3: No influence | 4.7 percentage of patients |
| Medtronic CareLink® Network | Patient Ease of Use of, and Satisfaction With the Medtronic CareLink® Monitor (Including Percentage of Patients Who Prefer Follow up With Medtronic CareLink® Compared to Traditional In-clinic Device Follow-up) | Question 3: Unsafe | 0 percentage of patients |
| Medtronic CareLink® Network | Patient Ease of Use of, and Satisfaction With the Medtronic CareLink® Monitor (Including Percentage of Patients Who Prefer Follow up With Medtronic CareLink® Compared to Traditional In-clinic Device Follow-up) | Question 3: Missing data | 0.7 percentage of patients |
Time and Cost Savings for Patients
Time frame: Baseline to max. 12 months
Time and Costs Savings for Physicians
Time frame: Baseline to max. 12 months